The expression of the molecules associated with NK cell activity including granzyme A, and have also been found to be increased in COVID-19 patients as compared to healthy controls (14, 15), while there are conflicting reports on changes in NKG2C expression (15, 16). This evidence concerns the gene KLRC2 and COVID-19.